Skip to main content
BEONE MEDICINES LTD. logo

BEONE MEDICINES LTD. — Investor Relations & Filings

Ticker · 688235 ISIN · CNE100005XT6 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 727 across all filing types
Latest filing 2024-10-31 Share Issue/Capital Cha…
Country CN China
Listing Shanghai Stock Exchange 688235

About BEONE MEDICINES LTD.

https://beonemedicines.com/

BEONE MEDICINES LTD. is a biopharmaceutical company focused on the research, development, and commercialization of innovative therapeutic solutions, primarily in the field of oncology. The company specializes in the discovery of targeted small molecule drugs and biologics designed to address unmet medical needs in cancer treatment. Its research and development pipeline emphasizes precision medicine, utilizing advanced molecular biology and medicinal chemistry platforms to identify novel drug candidates. BEONE MEDICINES LTD. aims to improve patient outcomes by developing high-efficacy, low-toxicity therapies that target specific genetic drivers of disease. The company maintains a strong focus on clinical-stage development and strategic collaborations to advance its portfolio of next-generation medicines.

Recent filings

Filing Released Lang Actions
港股公告：翌日披露报表
Share Issue/Capital Change Classification · 95% confidence The document is a detailed disclosure report about changes in issued shares and treasury shares, including share issuance under equity plans and share repurchases, with references to Hong Kong Stock Exchange Listing Rules (Main Board and GEM). It includes specific share counts, dates, and confirmations of compliance with listing rules. The document is a regulatory disclosure related to share capital changes rather than a full financial report or announcement of a report. It is not an announcement of a report publication but a substantive disclosure of share capital movements. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length is 4059 characters, which is sufficient for a detailed disclosure but not a full annual or interim report. Hence, the classification is SHA with high confidence.
2024-10-31 Chinese
港股公告：翌日披露报表
Transaction in Own Shares Classification · 95% confidence The document is a detailed disclosure report about changes in issued shares, treasury shares, share repurchases, and sales of treasury shares by the company, referencing specific Hong Kong Stock Exchange Listing Rules (Main Board and GEM). It includes tables of share counts before and after events, prices, dates, and confirmations of compliance with listing rules. The document is a regulatory disclosure about share capital changes and share repurchase activities, not a full financial report or earnings release. It is not a report publication announcement since it contains substantive data and detailed disclosures. The content matches the definition of a Transaction in Own Shares (POS) filing, which covers company buybacks or sales of its own shares. Therefore, the correct classification is POS with high confidence.
2024-10-30 Chinese
港股公告：审计委员会会议日期
Regulatory Filings Classification · 95% confidence The document is a short announcement from BeiGene, Ltd. regarding the date of the Audit Committee meeting to review and approve financial results for the three and nine months ended September 30, 2024. It does not contain the actual financial results or detailed financial statements but merely announces the upcoming meeting and the intention to review and release the financial results. The document length is only 684 characters, indicating it is a brief notice rather than a full report. According to the 'Menu vs Meal' rule, this is an announcement about a report or financial results to be published later, not the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for such announcements that do not fit other specific categories.
2024-10-29 Chinese
港股公告：董事名单及其角色与职能
Governance Information Classification · 95% confidence The document lists the members of the board of directors and their roles and committee memberships. It includes details about executive, non-executive, and independent non-executive directors, as well as their committee assignments. There is no financial data, no mention of a meeting date or voting results, no discussion of management changes, no earnings or financial results, and no indication of a report being attached or published. The content is focused on governance structure and board composition, which fits the definition of Governance Information (CGR). The document length is short but contains substantive governance details rather than just an announcement or notice. Therefore, the appropriate classification is CGR with high confidence.
2024-10-28 Chinese
百济神州有限公司关于公司独立非执行董事逝世的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the death of an independent non-executive director of the company. It includes details about the current composition of the board and the company's intention to appoint a new director. There is no financial data, no report attached or referenced, and no mention of regulatory filings or certifications. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2024-10-28 Chinese
港股公告：翌日披露报表
Transaction in Own Shares Classification · 100% confidence The document is a detailed disclosure report about changes in issued shares, treasury shares, share repurchases, and sales of treasury shares by the company, referencing specific Hong Kong Stock Exchange Listing Rules (Main Board and GEM). It includes tables of share counts, issuance events, prices, and confirmations of compliance with regulatory requirements. The document is not an announcement of a report but the actual disclosure itself, containing substantive data on share capital changes. This matches the description of a Transaction in Own Shares (POS) filing, which covers share repurchases and issuance activities. The document length is 4550 characters, sufficient to contain detailed data rather than a brief announcement. Therefore, the correct classification is POS.
2024-10-08 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.